Holo - HOT

MicroCloud Hologram Azioni (NASDAQ: HOLO)

Ultime notizie per MicroCloud Hologram (NASDAQ:HOLO) Azioni

MicroCloud Hologram

MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library.

MicroCloud Hologram Inc. - Ordinary Shares

MicroCloud Hologram Inc

HOLOGIC ORD

HOLOGRAPHIC STORAGE INC by Holographic Storage Ltd.

Holo

Holobeam Inc

Holoco Inc

Hologic Inc

Earnings

News

Comerica Q3 2024 Adj. EPS $1.37 Beats $1.16 Estimate, Sales $811.000M Miss $811.617M Estimate

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Adlai Nortye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANL#NASDAQ">ANL</a>) with a Buy and maintains $9 price target.

Price Target

Reiteration

Analyst Ratings

HC Wainwright & Co. Reiterates Buy on Adlai Nortye, Maintains $9 Price Target

HC Wainwright &amp; Co. analyst Edward White maintains Aura Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AURA#NASDAQ">AURA</a>) with a Buy and raises the price target from $21 to $22.

AURA

HC Wainwright & Co. Maintains Buy on Aura Biosciences, Raises Price Target to $22

The collaboration supports the licensing of part of Curiosity Stream&#39;s content portfolio in China, Hong Kong, and Macau, bringing 56 unique titles, amounting to 148 hours of premium factual content, to audiences across these territories through various platforms. The deal encompasses a diverse range of programming, from short-form documentary series to premium long-form content.

CURI

Curiosity Inks Strategic Distribution Partnership With Off The Fence; Deal Broadens Company's Footprint Across China, Hong Kong, And Macau

Guidance

CVS's Q3 Results Won't Meet Wall Street's Expectations; Plans To Back Away From Current 2024 Guidance

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates DRDGold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRD#NYSE">DRD</a>) with a Buy and maintains $13.25 price target.

HC Wainwright & Co. Reiterates Buy on DRDGold, Maintains $13.25 Price Target

Management

CVS Naming Caremark President David Joyner As Its New CEO

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates Avino Silver &amp; Gold Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASM#AMEX">ASM</a>) with a Buy and maintains $1.5 price target.

HC Wainwright & Co. Reiterates Buy on Avino Silver & Gold Mines, Maintains $1.5 Price Target

Biotech

Large Cap

Health Care

General

The European Medicines Agency's Committee For Medicinal Products For Human Use Has Adopted A Positive Opinion, Recommending Approval Of Novo Nordisk's Alhemo (Concizumab) As The First Once-Daily Subcutaneous Prophylactic Treatment For People Aged 12 Years Or Older With Hemophilia A Or B With Inhibitors.

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates First Majestic Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AG#NYSE">AG</a>) with a Buy and maintains $8.5 price target.

HC Wainwright & Co. Reiterates Buy on First Majestic Silver, Maintains $8.5 Price Target

The combined companies for the trailing twelve months have generated $235 million in revenue, increasing approximately&nbsp;25%&nbsp;quarter-over-quarter.

BTTR

Better Choice Expects Combined 2025 Pro Forma Basis Revenue And EBITDA To Be Approximately +$270M, And +$10M, Respectively

Better Choice Says Continues To Make Progress Towards Closing Of Its Acquisition Of SRx Health Solutions; Expects Transaction To Close In Late Q4 Of This Year Or Early Q1 Of 2025

Needham analyst Ami Fadia reiterates Neumora Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRA#NASDAQ">NMRA</a>) with a Buy and maintains $23 price target.

NMRA

Needham Reiterates Buy on Neumora Therapeutics, Maintains $23 Price Target

Based on sales trends and order intake in recent years, it expects further market share gains with domestic Chinese OEMs in the coming years.
With the seasonally strong fourth quarter remaining of the year, it reaffirms&nbsp;guidance of around 9.5-10.0% adjusted operating margin for 2024, but to be at the low end of this range.
&nbsp;

Autoliv Now Expects Full Year 2024 Organic Sales Growth To Be 1% Instead Of Previously Expected 2% Due To Unfavorable Market Mix Development

Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.53 by 7.55 percent. This is a 16.33 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $1.87 billion which beat the analyst consensus estimate of $1.80 billion by 3.78 percent. This is a 0.54 percent increase over sales of $1.86 billion the same period last year.

Earnings Beats

Regions Finl Q3 Adj $0.57 Beats $0.53 Estimate, Sales $1.87B Beat $1.80B Estimate

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Buy and maintains $400 price target.

ALNY

HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $400 Price Target

Autoliv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>) reported quarterly earnings of $1.84 per share which missed the analyst consensus estimate of $1.95 by 5.64 percent. The company reported quarterly sales of $2.56 billion which beat the analyst consensus estimate of $2.53 billion by 0.89 percent. This is a 1.58 percent decrease over sales of $2.60 billion the same period last year.

Earnings Misses

Autoliv Q3 2024 Adj EPS $1.84 Misses $1.95 Estimate, Sales $2.56B Beat $2.53B Estimate

HC Wainwright &amp; Co. analyst Amit Dayal reiterates Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) with a Buy and maintains $14 price target.

GEVO

HC Wainwright & Co. Reiterates Buy on Gevo, Maintains $14 Price Target

Needham analyst Ami Fadia reiterates Avadel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) with a Buy and maintains $22 price target.

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target

Needham analyst Mayank Tandon maintains WNS (Hldgs) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNS#NYSE">WNS</a>) with a Buy and lowers the price target from $70 to $60.

Needham Maintains Buy on WNS (Hldgs), Lowers Price Target to $60

MicroCloud Hologram (HOLO) has released an update. MicroCloud Hologram Inc., a tech firm listed on Nasdaq, has been notified of its stock's non-com...

MicroCloud Faces Nasdaq Minimum Bid Hurdle

MicroCloud Hologram (HOLO) has released an update. MicroCloud Hologram Inc. has announced a Convertible Note Purchase Agreement, allowing the purch...

MicroCloud Hologram Unveils Convertible Securities Deal

InMed Pharmaceuticals, Treasure Global, and MicroCloud Hologram are the 3 Penny Stocks to watch on August 22, based on&nbsp;TipRanks' Penny Stock S...

3 Penny Stocks to Watch Now, 8/22/24

MicroCloud Hologram (HOLO) has released an update. MicroCloud Hologram Inc., a tech firm incorporated in the Cayman Islands, has announced the issu...

MicroCloud Hologram Launches Convertible Notes

Brenmiller Energy, Mullen Automotive, and MicroCloud Hologram are the 3 Penny Stocks to watch on September 5, 2024, based on TipRanks' Penny Stock ...

3 Penny Stocks to Watch Now, 9/05/24

MicroCloud Hologram (HOLO) has released an update. MicroCloud Hologram Inc. has reported a substantial increase in total assets from RMB 160.6 mill...

MicroCloud Hologram's Assets Skyrocket

Once a mighty meme stock trading at over $129 per share, MicroCloud Hologram ($HOLO), a provider of holographic technology services, has been on a ...

MicroCloud Hologram (HOLO) Offers Impressive Tech but Sheds 99% of its Stock Value

MicroCloud Hologram (HOLO) has released an update. MicroCloud Hologram Inc. has successfully conducted its 2024 Annual General Meeting, approving a...

MicroCloud Hologram Revamps Share Structure

The story of MicroCloud Holograms is a peculiar one. We often hear tales about people who preceded the future&nbsp;and invented premature technolog...

3 Challenges Facing MicroCloud Hologram (HOLO)

These are the upcoming stock splits for the week of October 7 to October 11, based on&nbsp;TipRanks' Stock Splits Calendar. A stock split is a corp...

Upcoming Stock Splits This Week (October 7 to October 11) – Stay Invested

BNRG

HOLO

MULN

NVEE

SONY

Small Cap

Opinion

Press Releases

Thinking about buying stock in MicroCloud Hologram, CleanSpark, Cardiol Therapeutics, Atlasclear Holdings, or EZCORP?

Expansion Into Indonesia with Trading Firm to Open 30-50 Amusement Parks, Plus $6 Million Share Repurchase Program: Nasdaq: GDHG

New Amusement Park Attendance Record Set, Preceding Major Expansion into Indonesia with 30-50 New Park Openings, Plus $6 Million Share Repurchase Plan: Nasdaq: GDHG

Comments

MicroCloud Hologram

Notizie

Ultime notizie per MicroCloud Hologram (NASDAQ:HOLO) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO